This analysis demonstrates enhanced antimicrobial activity of daptomycin in nanoparticles against Staphylococcus aureus, shedding light on potential applications.
This study focused on determining whether the antimicrobial activity of the lipopeptide antibiotic daptomycin improves when it is loaded into chitosan-based nanoparticles (NPs). The nanoparticulate systems were developed through the ionic gelation method employing phytic acid as a crosslinking agent. Physicochemical characterisation of the nanoparticles (NPs) was carried out by measurements of particle size, polydispersity index (PDI), and zeta potential. Antimicrobial evaluation was performed using a susceptible S. aureus strain using the broth microdilution method. The results showed a particle size of 453.9 ± 4.7 nm, a polydispersity index of 0.245 ± 0.04, and a zeta potential of +29.4 ± 0.3 mV. Notably, the antimicrobial evaluation revealed that daptomycin reduces the minimum inhibitory concentration (MIC) from 64 to 4 μg/mL upon loading into the nanoparticle, demonstrating an interesting potential as a pharmaceutical nanoformulation.
No takes yet. Share an insight, caveat, or question.
Moncayo-Chaves et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: